** Drug developer Krystal Biotech's KRYS.O shares rise 9.75% to $171.96
** Co posts Q4 rev of $91.1 mln, beating analyst est of $90.5 mln, as per data compiled by LSEG
** Co's net income for the quarter was $45.5 million or $1.58 per share, compared with net income of $8.7 million or 31 cents per share a year ago
** Stock has risen 40.3% in the past 12 months
(Reporting by Padmanabhan Ananthan)
((Padmanabhan.Ananthan@thomsonreuters.com;))
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。